CDC Updates RSV Vaccination Recommendation for Adults
WEBJun 26, 2024 · Today, CDC updated its recommendation for the use of Respiratory Syncytial Virus (RSV) vaccines in people ages 60 and older. For this upcoming respiratory virus season, CDC recommends: Everyone ages 75 and older receive the RSV vaccine.
Should You Get the New RSV Vaccine? > News - Yale Medicine
WEBSep 25, 2023 · Respiratory syncytial virus (RSV) causes mild cold symptoms in most people but can lead to hospitalization and even death in older people and babies. But now, there are new immunizations aimed at older people, babies, and pregnant women who want to protect their newborns.
The new RSV vaccines for older adults - Mayo Clinic Press
WEBSep 19, 2023 · In May 2023, pharmaceutical companies GSK and Pfizer received approval from the U.S. Food and Drug Administration (FDA) for their RSV vaccines within weeks of each other. Both vaccines are currently available. Here’s what you need to know about RSV and the two new vaccines designed to protect against it.
FDA approves first vaccine for RSV, a moment six decades in the ... - CNN
WEBMay 3, 2023 · The US Food and Drug Administration approved the first vaccine against respiratory syncytial virus, known as RSV, and vaccines are in the works.
FDA Approves First Respiratory Syncytial Virus (RSV) Vaccine
WEBMay 4, 2023 · Today, the U.S. Food and Drug Administration approved Arexvy, the first respiratory syncytial virus (RSV) vaccine approved for use in the United States. Arexvy is approved for the prevention of...
Efficacy and Safety of an mRNA-Based RSV PreF Vaccine in Older …
WEBDec 13, 2023 · Respiratory syncytial virus (RSV) can cause substantial morbidity and mortality among older adults. An mRNA-based RSV vaccine, mRNA-1345, encoding the stabilized RSV prefusion F...
FDA approves Moderna’s mRNA RSV vaccine for older adults
WEBMay 31, 2024 · The US Food and Drug Administration has approved another vaccine that can help protect older people from respiratory syncytial virus, known as RSV. The shot, made by Moderna and sold under the name...
RSV Vaccines Are Finally Here after Decades of False Starts
WEBMar 20, 2023 · Pfizer has said its RSV vaccine for pregnant people is 82 percent effective against severe RSV in newborns for up to three months and 69 percent effective through six months. The committee...
U.S. FDA Approves ABRYSVO™, Pfizer’s Vaccine for the …
WEBMay 31, 2023 · Each year in the U.S., it is estimated that between 60,000 and 160,000 older adults are hospitalized and between 6,000 and 10,000 die due to RSV infection1. ABRYSVO’s approval will help offer older adults protection in the …
FDA advisers recommend world's first RSV vaccines, from ... - NBC News
WEBMar 1, 2023 · An FDA advisory committee has recommended that the agency approve two RSV vaccines for older people, one from Pfizer and another from GSK.